1,444 results on '"Holler, Ernst"'
Search Results
2. Acute Graft-Versus-Host Disease
3. Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002
4. Impact of pre-transplantation depression and anxiety on the outcome of allogeneic hematopoietic stem cell transplantation: a study from the Transplant Complications Working Party of the EBMT
5. The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
6. Analysis of long-term mortality after total body irradiation-based and melphalan-based chemotherapy conditioning for acute myeloid leukemia
7. Round-Robin test for the histological diagnosis of acute colonic Graft-versus-Host disease validating established histological criteria and grading systems
8. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD
9. A Day 14 Endpoint for Acute GVHD Clinical Trials
10. Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
11. Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial
12. Multimodal immune cell phenotyping in GI biopsies reveals microbiome-related T cell modulations in human GvHD
13. Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use
14. Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation
15. Fäkaler Mikrobiomtransfer bei GvHD und Komplikationen nach allogener Stammzelltransplantation: Ein vielversprechender Ansatz
16. Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia
17. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD
18. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification
19. Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation
20. Fecal Microbiota Transfer in Acute Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation.
21. Multiplexed imaging and automated signal quantification in formalin-fixed paraffin-embedded tissues by ChipCytometry
22. Strain specific differences in vitamin D3 response: impact on gut homeostasis
23. A genome-wide association study on hematopoietic stem cell transplantation reveals novel genomic loci associated with transplant outcomes
24. The MAGIC Algorithm Probability Predicts Treatment Response and Long-Term Outcomes to Second-Line Therapy for Acute Gvhd
25. Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation
26. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report
27. Incidence and Outcome of Atypical Manifestations of Chronic Graft-versus-Host Disease: Results From a Retrospective Single-Center Analysis
28. Heparanase wildtype is associated with a reduced incidence of transplant-associated systemic vasculopathies
29. A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy
30. Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study
31. Microbiota and Immune Response
32. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin
33. Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis
34. 1,25-dihydroxyvitamin-D3 but not the clinically applied marker 25-hydroxyvitamin-D3 predicts survival after stem cell transplantation
35. Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health
36. Ein vielversprechender Ansatz.
37. Acute Graft-Versus-Host Disease
38. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
39. Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial
40. Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis
41. Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects
42. A qualitative study on patients’ and their support persons’ preferences for receiving one longer consultation or two shorter consultations when being informed about allogeneic hematopoietic stem cell transplantation
43. Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy
44. Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis
45. IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
46. Mikrobiom und Immuntherapien bei Tumorerkrankungen
47. Long-term follow-up of rituximab in treatment of chronic graft-versus-host disease—single center experience
48. Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland
49. The utility of biomarkers in acute GVHD prognostication
50. MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.